Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1.

Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, Schumacher M, von Wolff G, Avrabos C, Touma C, Engblom D, Schütz G, Nave KA, Eder M, Wotjak CT, Sillaber I, Holsboer F, Wurst W, Deussing JM.

Science. 2011 Sep 30;333(6051):1903-7. doi: 10.1126/science.1202107. Epub 2011 Sep 1.

2.

Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1.

Wang XD, Labermaier C, Holsboer F, Wurst W, Deussing JM, Müller MB, Schmidt MV.

Eur J Neurosci. 2012 Aug;36(3):2360-7. doi: 10.1111/j.1460-9568.2012.08148.x. Epub 2012 Jun 4.

PMID:
22672268
3.

Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.

Merali Z, Khan S, Michaud DS, Shippy SA, Anisman H.

Eur J Neurosci. 2004 Jul;20(1):229-39.

PMID:
15245495
4.

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

Müller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MS, Droste SK, Kühn R, Reul JM, Holsboer F, Wurst W.

Nat Neurosci. 2003 Oct;6(10):1100-7. Epub 2003 Sep 14.

PMID:
12973355
5.

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J.

Nat Genet. 2000 Apr;24(4):415-9.

PMID:
10742109
6.

Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.

Hartmann J, Dedic N, Pöhlmann ML, Häusl A, Karst H, Engelhardt C, Westerholz S, Wagner KV, Labermaier C, Hoeijmakers L, Kertokarijo M, Chen A, Joëls M, Deussing JM, Schmidt MV.

Mol Psychiatry. 2017 Mar;22(3):466-475. doi: 10.1038/mp.2016.87. Epub 2016 May 31.

PMID:
27240530
7.

Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

Mathon DS, Lesscher HM, Gerrits MA, Kamal A, Pintar JE, Schuller AG, Spruijt BM, Burbach JP, Smidt MP, van Ree JM, Ramakers GM.

Neuroscience. 2005;130(2):359-67.

PMID:
15664692
8.

Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.

Gutiérrez-Mariscal M, de Gortari P, López-Rubalcava C, Martínez A, Joseph-Bravo P.

Psychoneuroendocrinology. 2008 Feb;33(2):198-213.

PMID:
18079066
9.

Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors.

Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR.

Science. 2004 Mar 5;303(5663):1512-4.

10.

Enriched environment impacts trimethylthiazoline-induced anxiety-related behavior and immediate early gene expression: critical role of Crhr1.

Sotnikov SV, Chekmareva NY, Schmid B, Harbich D, Malik V, Bauer S, Kuehne C, Markt PO, Deussing JM, Schmidt MV, Landgraf R.

Eur J Neurosci. 2014 Aug;40(4):2691-700. doi: 10.1111/ejn.12624. Epub 2014 May 20.

PMID:
24840018
11.

Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.

Peleg-Raibstein D, Pezze MA, Ferger B, Zhang WN, Murphy CA, Feldon J, Bast T.

Neuroscience. 2005;132(1):219-32.

PMID:
15780480
12.

Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.

Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, Zieglgänsberger W, Lutz B, Rammes G.

J Neurosci. 2006 May 24;26(21):5794-9. Erratum in: J Neurosci. 2006 Jun 14;26(24):table of contents.

13.

Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.

Spiga F, Lightman SL, Shekhar A, Lowry CA.

Neuroscience. 2006;138(4):1265-76. Epub 2006 Feb 20.

PMID:
16488545
14.

Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function.

Wallén-Mackenzie A, Nordenankar K, Fejgin K, Lagerström MC, Emilsson L, Fredriksson R, Wass C, Andersson D, Egecioglu E, Andersson M, Strandberg J, Lindhe O, Schiöth HB, Chergui K, Hanse E, Långström B, Fredriksson A, Svensson L, Roman E, Kullander K.

J Neurosci. 2009 Feb 18;29(7):2238-51. doi: 10.1523/JNEUROSCI.5851-08.2009.

16.

Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain.

Brinschwitz K, Dittgen A, Madai VI, Lommel R, Geisler S, Veh RW.

Neuroscience. 2010 Jun 30;168(2):463-76. doi: 10.1016/j.neuroscience.2010.03.050. Epub 2010 Mar 29.

PMID:
20353812
17.

The glutaminergic, GABAergic, dopaminergic but not cholinergic neurons are susceptible to anaesthesia-induced cell death in the rat developing brain.

Zhou ZW, Shu Y, Li M, Guo X, Pac-Soo C, Maze M, Ma D.

Neuroscience. 2011 Feb 3;174:64-70. doi: 10.1016/j.neuroscience.2010.10.009. Epub 2010 Nov 5.

PMID:
21056635
18.

Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity.

Schierloh A, Deussing J, Wurst W, Zieglgänsberger W, Rammes G.

Neurosci Lett. 2007 Apr 6;416(1):82-6. Epub 2007 Jan 26.

PMID:
17316992
19.
20.

Visualizing corticotropin-releasing hormone receptor type 1 expression and neuronal connectivities in the mouse using a novel multifunctional allele.

Kühne C, Puk O, Graw J, Hrabě de Angelis M, Schütz G, Wurst W, Deussing JM.

J Comp Neurol. 2012 Oct 1;520(14):3150-80. doi: 10.1002/cne.23082.

PMID:
22886732

Supplemental Content

Support Center